(RTTNews) - Propanc Biopharma, Inc. (PPCB), a biopharmaceutical company, announced that it is advancing key analytical development activities, including immunogenicity assay feasibility, pharmacokinetic method optimisation, and stability testing, to support the planned Phase 1b f